Skip to content

Drug interactions

Dapagliflozin + Letermovir

Severity: Minor

Dapagliflozin and Letermovir: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Letermovir may increase dapagliflozin exposure, possibly through inhibition of UGT1A1, its main metabolic pathway. Higher exposure could enhance glucose-lowering and volume-related effects, though the change is likely modest.

What this interaction means in plain words

Dapagliflozin and Letermovir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Dapagliflozin belongs to Endocrine; Letermovir belongs to Anti Virals.

Evidence level: Low

Why it happens

Letermovir may inhibit UGT1A1-mediated glucuronidation of dapagliflozin; the mechanism is not firmly established.

What to do

No dose change is usually required. Monitor blood glucose and hydration status during co-treatment.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dapagliflozin and Letermovir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dapagliflozin with Letermovir?

MediHelp rates the interaction as minor. Dapagliflozin and Letermovir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Letermovir may increase dapagliflozin exposure, possibly through inhibition of UGT1A1, its main metabolic pathway. Higher exposure could enhance glucose-lowering and volume-related effects, though the change is likely modest.

How serious is the interaction between Dapagliflozin and Letermovir?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change is usually required. Monitor blood glucose and hydration status during co-treatment.

What other medicines interact with Dapagliflozin?

MediHelp also lists interactions of Dapagliflozin with, for example, Chlorpropamide, Gliclazide, Glimepiride. The full list is on the Dapagliflozin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in